Study Papers on Blood Screening Market to 2021: Industry Size, Shares, Geographical Trends, Key Forecast and Overview
Geographically, the blood screening market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growth of this market can be attributed to the increasing adoption of nucleic acid tests (NAT) in this region. In addi
(EMAILWIRE.COM, October 02, 2018 ) Global blood screening market is categorized based on technology, product & service, end-user, and region. The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%. NAT segment is expected to grow at highest CAGR during forecast period. Download Free Sample Papers Now <||>rnhttp://www.rnrmarketresearch.com/contacts/request-sample?rname=310626 .
On the basis of product & service, the market is segmented into reagents & kits, instruments, and software & services. In 2016, the reagents and kits segment is expected to account for the largest share of the market. The repeated usage of reagents and kits is the key driving factor driving the growth of this segment. On the basis of end user, the market is segmented into blood banks and hospitals. In 2016, the blood banks segment is expected to account for the largest of the market.
Target Audience for this Report:
• Blood Screening Instruments and Reagents Manufacturers
• Blood Screening Software and Services Providers
• Blood Banks
• Hospitals
• Red Cross Societies
• Regulatory Bodies
• Research and Consulting Firms
• Government Bodies
Major factors contributing to the growth in this segment are increasing number of blood donations, rising incidence of various infectious diseases, and increasing disposable income to pay for advanced blood screening procedures including NAT-test.
Complete Report on Blood Screening Market spread across 150 Pages, Profiling 11 Companies and Supported with 97 Tables and 39 Figures is now available at http://www.rnrmarketresearch.com/blood-screening-market-by-technology-nucleic-acid-amplification-test-elisa-rapid-test-chemiluminescence-immunoassay-next-generation-sequencing-western-blotting-product-instrument-reagent-market-report.html .
Globally, the blood screening market is witnessing substantial growth due to factors such as increasing number of blood donations and blood donors, growing affordability and adoption of nucleic acid test (NAT) for blood screening, rising awareness regarding the safety of donated blood, growing demand for donated blood, and increasing prevalence/incidence of infectious diseases.
List of Tables
Table 1 Blood Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 2 Global Market, By Volume (Number of Tests), 2015
Table 3 North America: Market, By Volume (Number of Tests), 2015
Table 4 Europe: Market, By Volume (Number of Tests), 2015
Table 5 Asia: Market, By Volume (Number of Tests), 2015
The major players in this market include Grifols (Spain), Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Ortho Clinical Diagnostics, Inc. (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), bioMérieux (France),Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).
Get Discount on “Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecasts to 2021” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=310626 .
Value Addition for the Buyer:
This report aims to provide insights into global blood screening market. It provides valuable information on technology, product & service, end user, and region in market. Furthermore, information for these segments, by region, is also presented in this report. Leading players in market are profiled to study their product offerings and understand strategies undertaken by them to be competitive in this market.
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Market Share Analysis for NAT
4 Blood Screening Market Share Analysis
5 Competitive Situations and Trends
6 Product Launches
7 Regulatory Approvals
8 Agreements
9Partnerships
10 Acquisitions
11 Expansions
The major factors driving growth of this market are increasing number of blood donations and blood donors and rising awareness regarding safety of donated blood. In addition, increasing affordability and adoption of nucleic acid test (NAT) for blood screening, rising demand for donated blood, and increasing prevalence of infectious diseases are also driving growth of this market.
On the basis of product & service, the market is segmented into reagents & kits, instruments, and software & services. In 2016, the reagents and kits segment is expected to account for the largest share of the market. The repeated usage of reagents and kits is the key driving factor driving the growth of this segment. On the basis of end user, the market is segmented into blood banks and hospitals. In 2016, the blood banks segment is expected to account for the largest of the market.
Target Audience for this Report:
• Blood Screening Instruments and Reagents Manufacturers
• Blood Screening Software and Services Providers
• Blood Banks
• Hospitals
• Red Cross Societies
• Regulatory Bodies
• Research and Consulting Firms
• Government Bodies
Major factors contributing to the growth in this segment are increasing number of blood donations, rising incidence of various infectious diseases, and increasing disposable income to pay for advanced blood screening procedures including NAT-test.
Complete Report on Blood Screening Market spread across 150 Pages, Profiling 11 Companies and Supported with 97 Tables and 39 Figures is now available at http://www.rnrmarketresearch.com/blood-screening-market-by-technology-nucleic-acid-amplification-test-elisa-rapid-test-chemiluminescence-immunoassay-next-generation-sequencing-western-blotting-product-instrument-reagent-market-report.html .
Globally, the blood screening market is witnessing substantial growth due to factors such as increasing number of blood donations and blood donors, growing affordability and adoption of nucleic acid test (NAT) for blood screening, rising awareness regarding the safety of donated blood, growing demand for donated blood, and increasing prevalence/incidence of infectious diseases.
List of Tables
Table 1 Blood Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 2 Global Market, By Volume (Number of Tests), 2015
Table 3 North America: Market, By Volume (Number of Tests), 2015
Table 4 Europe: Market, By Volume (Number of Tests), 2015
Table 5 Asia: Market, By Volume (Number of Tests), 2015
The major players in this market include Grifols (Spain), Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Ortho Clinical Diagnostics, Inc. (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), bioMérieux (France),Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).
Get Discount on “Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecasts to 2021” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=310626 .
Value Addition for the Buyer:
This report aims to provide insights into global blood screening market. It provides valuable information on technology, product & service, end user, and region in market. Furthermore, information for these segments, by region, is also presented in this report. Leading players in market are profiled to study their product offerings and understand strategies undertaken by them to be competitive in this market.
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Market Share Analysis for NAT
4 Blood Screening Market Share Analysis
5 Competitive Situations and Trends
6 Product Launches
7 Regulatory Approvals
8 Agreements
9Partnerships
10 Acquisitions
11 Expansions
The major factors driving growth of this market are increasing number of blood donations and blood donors and rising awareness regarding safety of donated blood. In addition, increasing affordability and adoption of nucleic acid test (NAT) for blood screening, rising demand for donated blood, and increasing prevalence of infectious diseases are also driving growth of this market.
Contact Information:
ReportsnReports
Mr. Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results